4 views left Get unlimited views with a free account

Subscribe to GlobalData Explorer

Explore the latest trends and actionable insights on the Down Syndrome Clinical Trials to inform business strategy and pinpoint opportunities and risks.

Number of ongoing Clinical Trials (for drugs) involving Down Syndrome by Phase

Industry: Pharmaceuticals
Current: Other Industry Indicators

There are currently 16 ongoing clinical trials involving Down Syndrome
Of the 16 trials,4 trials are in Phase II
Furthermore, 4 trials are in Phase III

Number of ongoing Clinical Trials (for drugs) involving Down Syndrome by Phase

View as table

The global pharmaceutical industry is steadily developing new drugs for Down Syndrome, a Genetic Disorders. North America boasts of the highest number of ongoing clinical trials involving Down Syndrome. Asia-Pacific and Europe are among some of the other prominent regions involved in Down Syndrome-related drug trials.

Children's Oncology Group: The leading ongoing Down Syndrome-related clinical trials sponsor

Children's Oncology Group is the top sponsor for Down Syndrome-related ongoing clinical trials.

University Medical Center Utrecht, Annovis Bio Inc, CIncinnati Children's Hospital Medical Center, and Nagasaki University are a few other notable sponsors involving Down Syndrome.

A clinical trial sponsor can be a Company, Government, Individual, or Institution.

Explore the latest trends and actionable insights on the Down Syndrome Clinical Trials to inform business strategy and pinpoint opportunities and risks. Explore the latest trends and actionable insights on the Down Syndrome Clinical Trials to inform business strategy and pinpoint opportunities and risks. Visit Report Store